Archive for January, 2008
« Previous Entries Next Entries »Atrazine - the truth now has it’s boots on
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
Facinating!
Wikipedia - atrazine.
Hat tip: http://leiaorotulo.blogspot.com/
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
What the……..?
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
Turned on by a priest?
Hat tip
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Schering Plough - Peter Rost is “smokin’”
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
This is a “must read”!
Schering-Plough’s CEO Fred Hassan has two years left to retirement as he faces the most serious challenge to his personal legacy: One failed trial, two Congressional investigations, subpoenas from the New York State Attorney General, an SEC investigation, and a brutal 40% drop in Schering-Plough stock […]
Vytorin - in case you are missing them
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Vytorin - all aboard the bandwaggon
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
Connecticut Attorney General Richard Blumenthal (right) announced that his state will also be investigating Merck and Schering-Plough’s behavior relating to cholesterol blockbuster Vytorin, adding to the list of government entities probing aspects of the drug’s marketing.
WSJ
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Shire - Vyvance: a lack of attention?
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
Shire, Britain’s third largest drug-maker, slid to a two-year low on the back of concerns about demand for Vyvanse, its treatment for attention deficit hyperactivity disorder in children.
Investment research house Sanford Bernstein cut its recommendation to “underperform” from “market perform” and slashed its target price to 910p from £11.20. Analyst […]
Big Pharma’s Big Problem contd. - “an entire generation” laid off
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
2007 was a brutal one for layoffs in Big Pharma.
With revenues under pressure across the sector, expect those big job cuts to continue, said Regent Atlantic Capital in a recent report, “The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities.” “No one can precisely predict how many additional people […]
Breast Cancer Screening Co-Pay Could Hurt Insurers’ Bottom Line
Tuesday, January 29th, 2008Submitted by BioHealth Investor, Med Tech Sentinel
A new study in The New England Journal of Medicine found that a modest insurance co-pay was enough to deter many older women from getting potentially life-saving mammograms.
The study examined 366,475 women between the ages of 65 to 69 enrolled at 174 Medicare managed-care plans. Screening rates were 8.3% […]
Monday’s Top Biotech & Medical Stocks
Tuesday, January 29th, 2008Submitted by BioHealth Investor
Biotechnology
ACORDA THERAPEUTICS [ACOR] +25.25%
TRANSDEL PHARMACTL [TDLP.OB] +17.47%
BIODELIVERY SCI INTL [BDSI] +14.52%
MEDIVATION INC [MDVN] +12.46%
I G I INC [IG] +8.97%
Diagnostic Substances
IMMUCELL CP [ICCC] +9.66%
ICAGEN, INC. [ICGN] +7.80%
IMMUNOMEDICS INC [IMMU] +7.58%
ISTA PHARMACTLS [ISTA] +7.20%
INTERLEUKIN GENETICS [ILI] +6.80%
Drug Delivery
EMISPHERE TECH [EMIS] +19.00%
DELCATH SYSTEMS INC [DCTH] +13.50%
PENWEST PHARM CO [PPCO] +11.88%
NEKTAR THERAPEUTIC [NKTR] +2.88%
BENTLEY […]
Now Peter Rost touches a nerve at Schering Plough
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
Ouch!
Hot on the heels of Matt Herper !
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
ID lubricants
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
I knew a girl like this once - but we split up (I’ll tell you why in the comments).
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Great quote
Tuesday, January 29th, 2008Submitted by PharmaGossip Blog
Sometimes I think the surest sign that intelligent life exists elsewhere in the universe is that none of it has tried to contact us.
Bill Watterson
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Joni Mitchell - Chinese Cafe
Monday, January 28th, 2008Submitted by PharmaGossip Blog
Visit 1800blogger to see all of our industry leading blogs
Rating 3.00 out of 5
[?]
Sanofi - Aventis - idraparinux: bleeding clinical trials
Monday, January 28th, 2008Submitted by PharmaGossip Blog
Sanofi-Aventis’ experimental stroke drug idraparinux caused more bleeding in some patients than a standard treatment in a study stopped ahead of schedule in 2005, researchers writing in The Lancet said.
Patients in the late-stage trial had “significantly” more bleeding after an injection of the medicine than those taking a standard oral blood-thinner, […]
Séance - Feb 27th, London
Monday, January 28th, 2008 Submitted by PharmaGossip Blog
European Medical Writers Association and Institute of Clinical Research are delighted to invite you to their first joint symposium. The theme is the “hot topic” of the ethical minefield of publishing clinical trial results.
Patients nowadays wish to have more and more information about their medicines, and the pharmaceutical industry is […]
More on Pharma blogger politics
Monday, January 28th, 2008Submitted by PharmaGossip Blog
Aubrey Blumsohn’s analysis.
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
The Whytorin Saga - Forbes’ Matt Herper gets a letter
Monday, January 28th, 2008Submitted by PharmaGossip Blog
Here is a letter Schering Plough’s Ken Banta sent on Friday to Matt Herper, Associate Editor at Forbes demanding corrections and apologies for this story that ran in the magazine about the ENHANCE study, Schering-Plough, and CEO Fred Hassan.
Matt,
Thanks for discussing the articles on Schering-Plough and our CEO that ran […]
PhRMA’s Johnson admits to “backlash”
Monday, January 28th, 2008Submitted by PharmaGossip Blog
In a number of states across the country, there is backlash building against [pharma] sales and marketing,” said Ken Johnson, senior VP for the Pharmaceutical Research and Manufacturers of America.
“This isn’t five years ago. There are new challenges with respect to safety, to sales and […]
Vytorin - Merrill Goozner writes
Monday, January 28th, 2008Submitted by PharmaGossip Blog
The lessons to be learned.
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Pfizer’s Transformation Gun
Monday, January 28th, 2008Submitted by PharmaGossip Blog
Very ’70’s punk.
Hat tip: Giles. Don’t lose touch.
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Merck, Schering Plough - we have ways to make you cooperate
Sunday, January 27th, 2008Submitted by PharmaGossip Blog
Subpoenas
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Big Pharma’s Big Problem contd - a Hollywood view
Sunday, January 27th, 2008Submitted by PharmaGossip Blog
For 25 years, the drug industry has imitated the basic business model of Hollywood. Pharmaceutical executives, like movie moguls, have focused on creating blockbusters. They introduce products that they hope will appeal to the masses, and then they promote them like mad. The strategy has created not only Fosamax and Lipitor […]
Guess what this vending machine dispenses
Sunday, January 27th, 2008Submitted by PharmaGossip Blog
Answer
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Introducing Amy - cheerleader drug rep
Sunday, January 27th, 2008Submitted by PharmaGossip Blog
Amy’s MySpace
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
SiCKO gets Oscar nomination - a letter from Michael Moore
Sunday, January 27th, 2008Submitted by PharmaGossip Blog
“Sicko” Gets the Oscar High-Five …a note from Michael Moore
January 25, 2008
Friends,
I just wanted to drop you a note to let you know (if you didn’t already) the good news that “Sicko” has been nominated for this year’s Academy Award for Best Documentary. It was a pleasant surprise when we got the […]
